Probucol Protects Against Atherosclerosis Through Lipid-lowering and Suppressing Immune Maturation of CD11c+ Dendritic Cells in STZ-induced Diabetic LDLR-/- Mice

Journal of Cardiovascular Pharmacology

Volumn 65, Issue 6, 2015, Pages 620-627

  Zhu, Hong ^a   Jin, Xueting ^a   Zhao, Jingjing ^a   Dong, Zhen ^b   Ma, Xin ^a   Xu, Fang ^c   Huang, Wei ^c   Liu, George ^c   Zou, Yunzeng ^a   Wang, Keqiang ^a   Hu, Kai ^a   Sun, Aijun ^a   Ge, Junbo ^a  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c PEKING UNIVERSITY   (China)

Author keywords

atherosclerosis; dendritic cells; diabetes; LDLR mice; ox LDL; probucol; streptozotocin

Indexed keywords

B7 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HLA DR ANTIGEN; INTERLEUKIN 12P70; INTERLEUKIN 4; MHC II PROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN; PROBUCOL; PROTEIN; T6 ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ANTILIPEMIC AGENT; AUTACOID; BIOLOGICAL MARKER; CHOLESTEROL; CYTOKINE; GLYCOPROTEIN P 15095; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; STREPTOZOCIN;

ABDOMINAL AORTA; ANIMAL CELL; AORTA ARCH; AORTA SINUS; ARTICLE; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY; CD11C + DENDRITIC CELL; CELL MATURATION; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; FLUORESCENCE ACTIVATED CELL SORTING; HEART PROTECTION; IN VITRO STUDY; LEFT SUBCLAVIAN ARTERY; LIPID DIET; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; THORACIC AORTA; ANIMAL; AORTIC DISEASES; ATHEROSCLEROSIS; BLOOD; CELL CULTURE; CHEMICALLY INDUCED; DEFICIENCY; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC ANGIOPATHIES; DOWN REGULATION; DRUG EFFECTS; GENETICS; HUMAN; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM;

ANIMALS; ANTIGENS, CD11C; AORTIC DISEASES; ATHEROSCLEROSIS; BIOMARKERS; CELLS, CULTURED; CHOLESTEROL; CYTOKINES; DENDRITIC CELLS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC ANGIOPATHIES; DIET, HIGH-FAT; DOWN-REGULATION; HUMANS; HYPOLIPIDEMIC AGENTS; INFLAMMATION MEDIATORS; LIPOPROTEINS, LDL; MALE; MICE, KNOCKOUT; PROBUCOL; RECEPTORS, LDL; STREPTOZOCIN;

EID: 84934901647     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/FJC.0000000000000234     Document Type: Article

References (35)

1. Bobryshev YV. Dendritic cells in atherosclerosis: current status of the problem and clinical relevance. Eur Heart J. 2005;26:1700-1704.
2. Ludewig B, Zinkernagel RM, Hengartner H. Arterial inflammation and atherosclerosis. Trends Cardiovasc Med. 2002;12:154-159.
3. Link A, Bohm M. Potential role of dendritic cells in atherogenesis. Cardiovasc Res. 2002;55:708-709.
4. Yilmaz A, Lochno M, Traeg F, et al. Emergence of dendritic cells in rupture-prone regions of vulnerable carotid plaques. Atherosclerosis. 2004;176:101-110.
5. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature. 1998;392:245-252.
6. Banchereau J, Briere F, Caux C, et al. Immunobiology of dendritic cells. Annu Rev Immunol. 2000;18:767-811.
7. Austyn JM. Dendritic cells. Curr Opin Hematol. 1998;5:3-15.
8. Lord RS, Bobryshev YV. Clustering of dendritic cells in athero-prone areas of the aorta. Atherosclerosis. 1999;146:197-198.
9. Nickel T, Schmauss D, Hanssen H, et al. oxLDL uptake by dendritic cells induces upregulation of scavenger-receptors, maturation and differentiation. Atherosclerosis. 2009;205:442-450.
10. Sun J, Hartvigsen K, Chou MY, et al. Deficiency of antigen-presenting cell invariant chain reduces atherosclerosis in mice. Circulation. 2010; 122:808-820.
11. Paulson KE, Zhu SN, Chen M, et al. Resident intimal dendritic cells accumulate lipid and contribute to the initiation of atherosclerosis. Circ Res. 2010;106:383-390.
12. Yamashita S, Matsuzawa Y: Where are we with probucol: a new life for an old drug? Atherosclerosis. 2009;207:16-23.
13. Wu BJ, Kathir K, Witting PK, et al. Antioxidants protect from atherosclerosis by a heme oxygenase-1 pathway that is independent of free radical scavenging. J Exp Med. 2006;203:1117-1127.
14. Stocker R. Molecular mechanisms underlying the antiatherosclerotic and antidiabetic effects of probucol, succinobucol, and other probucol analogues. Curr Opin Lipidol. 2009;20:227-235.
15. Zhong JK, Guo ZG, Li C, et al. Probucol alleviates atherosclerosis and improves high density lipoprotein function. Lipids Health Dis. 2011;10:210.
16. Kasai T, Miyauchi K, Kubota N, et al. Probucol therapy improves longterm (>10-year) survival after complete revascularization: a propensity analysis. Atherosclerosis. 2012;220:463-469.
17. Su W, Sun A, Xu D, et al. Tongxinluo inhibits oxidized low-density lipoprotein-induced maturation of human dendritic cells via activating peroxisome proliferator-activated receptor gamma pathway. J Cardiovasc Pharmacol. 2010;56:177-183.
18. Ge J, Jia Q, Liang C, et al. Advanced glycosylation end products might promote atherosclerosis through inducing the immune maturation of dendritic cells. Arterioscler Thromb Vasc Biol. 2005;25:2157-2163.
19. Luo Y, Liang C, Xu C, et al. Ciglitazone inhibits oxidized-low density lipoprotein induced immune maturation of dendritic cells. J Cardiovasc Pharmacol. 2004;44:381-385.
20. Sun A, Liu H, Wang S, et al. Salvianolic acid B suppresses maturation of human monocyte-derived dendritic cells by activating PPARgamma. Br J Pharmacol. 2011;164:2042-2053.
21. Packard RR, Maganto-Garcia E, Gotsman I, et al. CD11c(+) dendritic cells maintain antigen processing, presentation capabilities, and CD4(+) T-cell priming efficacy under hypercholesterolemic conditions associated with atherosclerosis. Circ Res. 2008;103:965-973.
22. Koopman R, Schaart G, Hesselink MK. Optimisation of oil red O staining permits combination with immunofluorescence and automated quantification of lipids. Histochem Cell Biol. 2001;116:63-68.
23. Rains JL, Jain SK. Oxidative stress, insulin signaling, and diabetes. Free Radic Biol Med. 2011;50:567-575.
24. Choy K, Beck K, Png FY, et al. Processes involved in the site-specific effect of probucol on atherosclerosis in apolipoprotein E gene knockout mice. Arterioscler Thromb Vasc Biol. 2005;25:1684-1690.
25. Bird DA, Tangirala RK, Fruebis J, et al. Effect of probucol on LDL oxidation and atherosclerosis in LDL receptor-deficient mice. J Lipid Res. 1998;39:1079-1090.
26. Inagaki M, Nakagawa-Toyama Y, Nishida M, et al. Effect of probucol on antioxidant properties of HDL in patients with heterozygous familial hypercholesterolemia. J Atheroscler Thromb. 2012;19:643-656.
27. Mora S, Glynn RJ, Ridker PM. High-density lipoprotein cholesterol, size, particle number, and residual vascular risk after potent statin therapy. Circulation. 2013;128:1189-1197.
28. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352:1685-1695.
29. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105:1135-1143.
30. Koltsova EK, Ley K. How dendritic cells shape atherosclerosis. Trends Immunol. 2011;32:540-547.
31. Kofler S, Sisic Z, Shvets N, et al. Expression of circulatory dendritic cells and regulatory T-cells in patients with different subsets of coronary artery disease. J Cardiovasc Pharmacol. 2011;57:542-549.
32. Van Vre EA, Van Brussel I, Bosmans JM, et al. Dendritic cells in human atherosclerosis: from circulation to atherosclerotic plaques. Mediators Inflamm. 2011;2011:941396.
33. Liu P, Yu YR, Spencer JA, et al. CX3CR1 deficiency impairs dendritic cell accumulation in arterial intima and reduces atherosclerotic burden. Arterioscler Thromb Vasc Biol. 2008;28:243-250.
34. Li T, Chen W, An F, et al. Probucol attenuates inflammation and increases stability of vulnerable atherosclerotic plaques in rabbits. Tohoku J Exp Med. 2011;225:23-34.
35. Takeda M, Yamashita T, Sasaki N, et al. Oral administration of an active form of vitamin D3 (calcitriol) decreases atherosclerosis in mice by inducing regulatory T cells and immature dendritic cells with tolerogenic functions. Arterioscler Thromb Vasc Biol. 2010;30:2495-2503.